Guided Therapeutics (GTHP) Return on Capital Employed Growth (1y) (2013 - 2026)
Guided Therapeutics (GTHP) Return on Capital Employed Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 216.00 |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | -48.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 773.00 |
| Dec 31, 2025 | -61.00 |
| Sep 30, 2025 | -356.00 |
| Jun 30, 2025 | -678.00 |
| Mar 31, 2025 | -3,325.00 |
| Dec 31, 2024 | -7,027.00 |
| Sep 30, 2024 | -10,086.00 |
| Jun 30, 2024 | -14,649.00 |
| Mar 31, 2024 | -34,797.00 |
| Dec 31, 2023 | -15,262.00 |
| Sep 30, 2023 | 2,936.00 |
| Jun 30, 2023 | 14,501.00 |
| Mar 31, 2023 | 36,926.00 |
| Dec 31, 2022 | 20,580.00 |
| Sep 30, 2022 | 4,654.00 |
| Jun 30, 2022 | -264.00 |
| Mar 31, 2022 | 3,559.00 |
| Dec 31, 2021 | 4,688.00 |
| Sep 30, 2021 | 5,517.00 |
| Jun 30, 2021 | 4,071.00 |